Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury

• Nuria Maicas,

  Affiliation Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands

  ⨯
• Johan van der Vlag,

  Affiliation Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands

  ⨯
• Janin Bublitz,

  Affiliation Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands

  ⨯
• Sandrine Florquin,

  Affiliation Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands

  ⨯
• Marinka Bakker-van Bebber,

  Affiliation Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands

  ⨯
• Charles A. Dinarello,

  Affiliations Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands, Department of Medicine, University of Colorado Health Sciences Center Denver, Colorado, United States of America

  ⨯
• Vivienne Verweij,

  Affiliation Department of Pharmacology and Toxicology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands

  ⨯
• Roos Masereeuw,

  Affiliation Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands

  ⨯
• Leo A. Joosten,

  Affiliation Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands

  ⨯
• Luuk B. Hilbrands

  * E-mail: Luuk.hilbrands@radboudumc.nl

  Affiliation Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands

  http://orcid.org/0000-0002-4935-9765

  ⨯